Summary
The Appellate Division, First Department reversed an order that had dismissed Sonenshine Partners’ quantum meruit/unjust enrichment claim while allowing its breach of contract claim to proceed. The court held that the nondisclosure agreement’s provision concerning a future financial-advisory engagement was an unenforceable agreement to agree because it omitted essential terms. The court concluded that the complaint adequately pleaded quantum meruit/unjust enrichment and that the claim was not barred by General Obligations Law § 5-701(a)(10).
Holdings
- The relevant provision was an unenforceable agreement to agree because it left essential terms, including the scope of Sonenshine Partners' role, the investment-banking services to be provided, and the fees, for future negotiation.
- Sonenshine Partners stated a claim for quantum meruit and unjust enrichment, and the claim was not barred by General Obligations Law § 5-701(a)(10) because the alleged services involved informing Duravant whether to acquire Maillis or one of its subsidiaries rather than merely acting as an intermediary in negotiating or consummating a business opportunity.
Questions Presented
- Whether the nondisclosure agreement created an enforceable contract requiring Duravant to engage or compensate Sonenshine Partners as a financial advisor.
- Whether Sonenshine Partners adequately stated a quantum meruit or unjust enrichment claim notwithstanding New York General Obligations Law § 5-701(a)(10).
Disposition
reversed
Cases Cited (9)
- Carmon v Soleh Boneh Ltd., 206 AD2d 450 (2d Dept 1994), lv denied 85 NY2d 804 (1995)(followed)
- Cobble Hill Nursing Home v Henry & Warren Corp., 74 NY2d 475, 482 (1989), cert denied 498 US 816 (1990)(followed)
- Foros Advisors v Digital Globe Inc., 333 F Supp 3d 354, 361 (SD NY 2018)(followed)
- Schneider v Jarmain, 85 AD3d 581, 582 (1st Dept 2011)(followed)
- Matter of 166 Mamaroneck Ave. Corp. v 151 E. Post Rd. Corp., 78 NY2d 88 (1991)(followed)
- Cowen & Co, LLC v Fiserv, Inc., 141 AD3d 18 (1st Dept 2016)(distinguished)
- JF Capital Advisors, LLC v Lightstone Group, LLC, 25 NY3d 759, 766 (2015)(followed)
- Dorfman v Reffkin, 144 AD3d 10, 19 (1st Dept 2016)(followed)
- Chapman, Spira & Carson, LLC v Helix BioPharma Corp., 115 AD3d 526, 528 (1st Dept 2014)(followed)
Cited In (0)
No citing cases on record yet.